Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Insight Molecular Diagnostics Inc. - Common Stock
(NQ:
IMDX
)
4.250
-0.070 (-1.62%)
Streaming Delayed Price
Updated: 3:35 PM EDT, Aug 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
45,406
Open
4.290
Bid (Size)
4.250 (300)
Ask (Size)
4.270 (200)
Prev. Close
4.320
Today's Range
4.010 - 4.365
52wk Range
2.330 - 8.510
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Oncocyte Eyes Faster, Less Invasive Heart Transplant Rejection Testing
↗
Today 14:02 EDT
Insight Molecular Diagnostics discussed the potential use of donor-derived cell-free DNA testing in heart transplant surveillance during a virtual session featuring transplant cardiologist Dr. Max...
Via
MarketBeat
Oncocyte Q2 Earnings Call Highlights
↗
August 10, 2026
Oncocyte (NASDAQ:IMDX) executives said they continue to target FDA marketing authorization for the GraftAssureDx kidney-transplant rejection test later this year, while preparing for a commercial...
Via
MarketBeat
Topics
Earnings
Performance
YTD
-40.6%
-40.6%
1 Month
-10.3%
-10.3%
3 Month
-33.1%
-33.1%
6 Month
-21.2%
-21.2%
1 Year
+59.2%
+59.2%
More News
Read More
IMDX Q1 2026 Earnings Call Transcript
↗
May 13, 2026
Via
The Motley Fool
Topics
Earnings
Insight Molecular Diagnostics (NASDAQ:IMDX) Soars on 285% Revenue Beat and Key FDA Submission
↗
March 26, 2026
Via
Chartmill
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Exploring Insight Molecular's Earnings Expectations
↗
August 08, 2025
Via
Benzinga
These stocks are moving in today's session
↗
April 14, 2026
Via
Chartmill
Topics
Artificial Intelligence
INSIGHT MOLECULAR DIAGNOSTIC (NASDAQ:IMDX) Stock Plummets 11.8% on Q3 Earnings Miss
↗
November 10, 2025
Via
Chartmill
A Look at Insight Molecular's Upcoming Earnings Report
↗
November 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
August 19, 2025
Via
Benzinga
Earnings Scheduled For August 11, 2025
↗
August 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
July 25, 2025
Via
Benzinga
Frequently Asked Questions
Is Insight Molecular Diagnostics Inc. - Common Stock publicly traded?
Yes, Insight Molecular Diagnostics Inc. - Common Stock is publicly traded.
What exchange does Insight Molecular Diagnostics Inc. - Common Stock trade on?
Insight Molecular Diagnostics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Insight Molecular Diagnostics Inc. - Common Stock?
The ticker symbol for Insight Molecular Diagnostics Inc. - Common Stock is IMDX on the Nasdaq Stock Market
What is the current price of Insight Molecular Diagnostics Inc. - Common Stock?
The current price of Insight Molecular Diagnostics Inc. - Common Stock is 4.250
When was Insight Molecular Diagnostics Inc. - Common Stock last traded?
The last trade of Insight Molecular Diagnostics Inc. - Common Stock was at 08/17/26 03:35 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
